Oligodendroglioma pathophysiology: Difference between revisions

Jump to navigation Jump to search
Line 44: Line 44:
*[[Calcification]]s - important feature
*[[Calcification]]s - important feature
*Perifocal [[edema]] - rare
*Perifocal [[edema]] - rare
*Few tumors may exhibit eosinophilic granular bodies
*Few tumors may exhibit [[eosinophilic]] granular bodies
*Some tumors may show a spongioblastoma-like growth pattern.
*Some tumors may show a spongioblastoma-like growth pattern.


On microscopic histopathological analysis, [[anaplastic|anaplastic oligodendroglioma]] is characterized by:
On microscopic histopathological analysis, [[anaplastic|anaplastic oligodendroglioma]] is characterized by:
*Significant or brisk mitotic activity (>= 6 mitoses per 10 HPF)
*Significant or brisk [[mitotic activity]] (>= 6 mitoses per 10 HPF)
*[[vascular|Microvacular proliferation]]
*[[vascular|Microvacular proliferation]]
*[[Necrosis]]
*[[Necrosis]]

Revision as of 17:55, 7 October 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Oligodendroglioma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Oligodendroglioma from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

Staging

History & Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Oligodendroglioma pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Oligodendroglioma pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Oligodendroglioma pathophysiology

CDC on Oligodendroglioma pathophysiology

Oligodendroglioma pathophysiology in the news

Blogs on Oligodendroglioma pathophysiology

Directions to Hospitals Treating Oligodendroglioma

Risk calculators and risk factors for Oligodendroglioma pathophysiology

Overview

Pathophysiology

Pathogenesis

Genetics

  • Development of oligodendroglioma is the result from multiple genetic mutations.
  • Genes associated with the pathogenesis of oligodendroglioma include:[2][3][4][5]

Gross Pathology

  • On gross pathology, oligodendroglioma is characterized by a well-circumscribed, gelatinous, gray mass which may expand a gyrus and remodel the skull.[6]
  • Other characteristic gross pathological features associated with oligodendroglioma include:[6]
  • Common intracranial sites associated with oligodendroglioma include:[7]

Microscopic Pathology

On microscopic histopathological analysis, oligodendroglioma is characterized by:

  • Diffusely growing tumor
  • Highly cellular lesion composed of cells resembling fried eggs with:
    • Round nucleus - key feature
    • Distinct cell borders
    • Moderate-to-marked nuclear atypia
    • Clear cytoplasm
      • Some oligodendrogliomas have eosinophilic cytoplasm with focal perinuclear clearing
    • Acutely branched capillary sized vessels - "chicken-wire" like appearance.
      • Abundant, delicate appearing; may vaguely resemble a paraganglioma at low power
  • Calcifications - important feature
  • Perifocal edema - rare
  • Few tumors may exhibit eosinophilic granular bodies
  • Some tumors may show a spongioblastoma-like growth pattern.

On microscopic histopathological analysis, anaplastic oligodendroglioma is characterized by:

References

  1. General features of oligodendroglioma. Libre Pathology. http://librepathology.org/wiki/index.php/Oligodendroglioma#cite_note-1
  2. Yip S, Butterfield YS, Morozova O, Chittaranjan S, Blough MD, An J; et al. (2012). "Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers". J Pathol. 226 (1): 7–16. doi:10.1002/path.2995. PMC 3246739. PMID 22072542.
  3. Molecular genetics of oligodendroglioma. https://en.wikipedia.org/wiki/Oligodendroglioma
  4. Bettegowda C, Agrawal N, Jiao Y, Sausen M, Wood LD, Hruban RH; et al. (2011). "Mutations in CIC and FUBP1 contribute to human oligodendroglioma". Science. 333 (6048): 1453–5. doi:10.1126/science.1210557. PMC 3170506. PMID 21817013.
  5. Prognosis and treatment of oligodendroglioma. Wikipedia 2015. https://en.wikipedia.org/wiki/Oligodendroglioma
  6. 6.0 6.1 Gross appearance of oligodendroglioma. Dr Henry Knipe and Dr Frank Gaillard et al. http://radiopaedia.org/articles/oligodendroglioma
  7. Gross/radiologic findings of oligodendroglioma. Libre Pathology. http://librepathology.org/wiki/index.php/Oligodendroglioma


Template:WikiDoc Sources